Skip to main content

Soaring ointment prices are a dermatologic mystery

By The New York Times  
   August 10, 2012

Other than pharmacy benefit managers, which manage prescription drug plans, few other players in the health care market make decisions based on cost. When doctors write a prescription, they often fail to consider the price of the drug. And since many patients have prescription drug coverage, they also often ignore the cost. The situation can create a lucrative opening for some companies, especially in a low-profile corner of the industry like dermatology, where price increases might not attract broader notice.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.